Health
SARS-CoV-2 evolves antibody resistance in immunocompromised patient – News-Medical.Net
Researchers in the United States who tracked the evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in an immunocompromised patient found…
Researchers in the United States who tracked the evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in an immunocompromised patient found that convalescent plasma therapy was associated with the emergence of viral variants that were less susceptible to neutralizing antibodies.
The SARS-CoV-2 virus is the agent responsible for the coronavirus 2019 (COVID-19) pandemic that continues to pose a significant threat to global public health and the worldwide economy.
The team’s analysis…
-
Business23 hours agoThese 4 ASX mining stocks are rocketing as the rare earths boom intensifies
-
General20 hours agoBunbury man Stanley J Clemons sentenced for shooting neighbour’s dog
-
Noosa News23 hours agoLung cancer researchers identify ‘breakthrough’ patterns predictive of treatment success
-
Noosa News17 hours agoRoaring jet boats to return to Victoria for first time in 15 years